Nath Bio-Genes (India) Ltd - 537291 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Authum Investment & Infrastructure Ltd Nath Bio-Genes (India) Ltd - 537291 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Agri-Tech (India) Ltd & Emerald Seeds Pvt Ltd Nath Bio-Genes (India) Ltd - 537291 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 26, 2022 for Ashu Farms LLP & Agri-Tech (India) Ltd Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for the quarter ended on 30th June 2022 Nath Bio-Genes (India) Ltd - 537291 - Financial Results As On 30Th June 2022
Financial Results as on 30th June 2022 Nath Bio-Genes (India) Ltd - 537291 - Board Meeting Intimation for Approval Of Financial Results As On 30Th June 2022
Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2022 ,inter alia, to consider and approve financial results as on 30th June 2022 Nath Bio-Genes (India) Ltd - 537291 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018 Nath Bio-Genes (India) Ltd - 537291 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Authum Investment & Infrastructure Ltd Nath Bio-Genes (India) Ltd - 537291 - Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- DHIRAJ R RATHIDesignation :- Company Secretary and Compliance Officer Nath Bio-Genes (India) Ltd - 537291 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of Share Certificate